168 related articles for article (PubMed ID: 28666875)
1. In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression.
Lulli M; Cammalleri M; Granucci I; Witort E; Bono S; Di Gesualdo F; Lupia A; Loffredo R; Casini G; Dal Monte M; Capaccioli S
Biochem Biophys Res Commun; 2017 Aug; 490(3):977-983. PubMed ID: 28666875
[TBL] [Abstract][Full Text] [Related]
2. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
3. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
McGuire PG; Jones TR; Talarico N; Warren E; Das A
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
[TBL] [Abstract][Full Text] [Related]
5. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization.
Hu J; Song X; He YQ; Freeman C; Parish CR; Yuan L; Yu H; Tang S
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6810-7. PubMed ID: 22956610
[TBL] [Abstract][Full Text] [Related]
6. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy.
Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358
[TBL] [Abstract][Full Text] [Related]
7. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
Colombo ES; Menicucci G; McGuire PG; Das A
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Liu N; Chen L; Cai N
Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
[TBL] [Abstract][Full Text] [Related]
10. The role of cytochrome P450 epoxygenases in retinal angiogenesis.
Capozzi ME; McCollum GW; Penn JS
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4253-60. PubMed ID: 24917142
[TBL] [Abstract][Full Text] [Related]
11. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
13. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
Cheng G; He T; Xing Y
Eye (Lond); 2016 Jun; 30(6):877-87. PubMed ID: 26987588
[TBL] [Abstract][Full Text] [Related]
14. Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivo.
Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J
BMC Complement Altern Med; 2016 Jul; 16():231. PubMed ID: 27435599
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
16. Small interference RNA targeting vascular endothelial growth factor gene effectively attenuates retinal neovascularization in mice model.
Kong YC; Sun B; Zhao KX; Han M; Wang YC
Chin Med J (Engl); 2013; 126(8):1440-4. PubMed ID: 23595374
[TBL] [Abstract][Full Text] [Related]
17. Adrenomedullin-RAMP2 system is crucially involved in retinal angiogenesis.
Iesato Y; Toriyama Y; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yoshizawa T; Koyama T; Uetake R; Yang L; Yamauchi A; Tanaka M; Igarashi K; Murata T; Shindo T
Am J Pathol; 2013 Jun; 182(6):2380-90. PubMed ID: 23562442
[TBL] [Abstract][Full Text] [Related]
18. PF4 antagonizes retinal neovascularization via inhibiting PRAS40 phosphorylation in a mouse model of oxygen-induced retinopathy.
Cai S; Yang Q; Cao Y; Li Y; Liu J; Wang J; Zhang X; Liu L; Li X; Zhang Y
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165604. PubMed ID: 31740404
[TBL] [Abstract][Full Text] [Related]
19. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084
[TBL] [Abstract][Full Text] [Related]
20. Knockout of αA-crystallin inhibits ocular neovascularization.
Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]